SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-143452
Filing Date
2018-04-30
Accepted
2018-04-30 16:51:04
Documents
11
Period of Report
2018-05-31
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d505393ddef14a.htm DEF 14A 517139
2 GRAPHIC g5053931.jpg GRAPHIC 7263
3 GRAPHIC g5053932.jpg GRAPHIC 7163
4 GRAPHIC g505393a.jpg GRAPHIC 6094
5 GRAPHIC g505393a1.jpg GRAPHIC 518
6 GRAPHIC g505393b.jpg GRAPHIC 855
7 GRAPHIC g505393c.jpg GRAPHIC 922
8 GRAPHIC g505393d.jpg GRAPHIC 1015
9 GRAPHIC g505393g17n24.jpg GRAPHIC 41340
10 GRAPHIC g505393g38t37.jpg GRAPHIC 18190
11 GRAPHIC g505393g66b02.jpg GRAPHIC 20749
  Complete submission text file 0001193125-18-143452.txt   663012
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 18790704
SIC: 2834 Pharmaceutical Preparations